Product Specifications CAS Number: 218949-48-5 Peptide Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 Category: Peptides Subcategory: Muscle Growth & Performance Peptides Molecular Weight: 5136 g/mol Molecular Formula: CHNOS Synonyms: TH9507 Purity: 99% Packaging Format: 10 mg Storage Conditions: Store at -20C, avoid light exposure Designation: For Laboratory Research Use Only Key Characteristics of Tesamorelin (10 mg) Well-defined peptide identity with consistent composition and sequence, supporting repeatable experimental setups
While it doesn't provide enough glycine to offer sleep benefits, you still reap the benefits of the magnesium itself
BPC-157 is perhaps one of the most well-known peptides in the realm of tissue repair
This comprehensive comparison will explore their functions, potential advantages, scientific backing, and practical applications to help you determine which might deserve a place in your supplementation strategy
Key features include: 99% purity, confirmed by HPLC and mass spectrometry for analytical accuracy and research reproducibility Pentapeptide structurewith non-proteinogenic residues (Aib and D-amino acids) conferring exceptional metabolic stability and resistance to non-specific proteolytic degradation High receptor selectivitydemonstrating minimal activity on non-target pituitary hormones including ACTH, cortisol, prolactin, FSH, LH, and TSHdistinguishing it from less selective growth hormone secretagogues Potent GHS-R1a agonist activitywith ED = 2.3 nmol/kg in conscious animal models, comparable to GHRP-6 efficacy but with enhanced selectivity Lyophilized powder formatproviding extended shelf-life stability of up to 24 months when stored appropriately, with minimal degradation under recommended cold-storage conditions Widely utilized as a pharmacological tool compoundfor structure-activity relationship (SAR) investigations and receptor-ligand selectivity studies For laboratory research use only These properties support its use as ipamorelin for research across receptor pharmacology, endocrine signaling, and growth hormone axis investigations
